Hypozalix

Hypozalix is an artificial saliva substitute designed to mimic the electrolyte composition and lubricating properties of natural human saliva. Developed by BioProgress and distributed by Biocodex, it contains a balanced mixture of mineral salts, including calcium chloride, magnesium chloride, and potassium chloride. It is primarily indicated for the symptomatic treatment of xerostomia (dry mouth) resulting from medication use or radiotherapy for head and neck cancers. Additionally, it has been utilized in the prevention and management of chemotherapy-induced oral mucositis, particularly in leukemic patients. The product is available in various formulations, including an oral spray, mouthwash, and gel, and is regulated as a medical device or pharmaceutical product depending on the jurisdiction.

Brand names

HypozalixArtisial

Other names

artificial saliva